Literature DB >> 27598009

Stakeholder Engagement in Trial Design: Survey of Visitors to Critically Ill Patients Regarding Preferences for Outcomes and Treatment Options during Weaning from Mechanical Ventilation.

Karen E A Burns1,2,3, Sonu Karottaiyamvelil Jacob1, Valeria Aguirre1, Janice Gomes1, Sangeeta Mehta2,3,4, Leena Rizvi1.   

Abstract

RATIONALE: Stakeholder engagement in research is expected to provide unique insights, make research investments more accountable and transparent, and ensure that future research is applicable to patients and family members.
OBJECTIVES: To inform the design of a trial of strategies for weaning from mechanical ventilation, we sought to identify preferences of patient visitors regarding outcome and treatment measures.
METHODS: We conducted an interviewer-administered questionnaire of visitors of critically ill patients in two family waiting rooms serving three intensive care units (ICUs) in Toronto, Canada. Respondents rated the importance of general and ventilation-related outcomes in two hypothetical scenarios (before a first spontaneous breathing trial, and after a failed spontaneous breathing trial) and selected a preferred technique for the breathing trials. With regard to the patient they were visiting, respondents identified the most important outcome to them at ICU admission, during the ICU stay, and at ICU discharge.
MEASUREMENTS AND MAIN RESULTS: We analyzed 322 questionnaires (95.5% response rate). All outcomes were highly rated (average range: 7.82-9.74). Across scenarios, outcomes rated as most important were ICU and hospital survival (9.72, 9.70), avoiding complications (9.45), quality of life (9.394), patient comfort (9.393), and returning to previous living arrangements (9.31). Overall, the most important ventilation-related outcomes were being ventilator-free (8.95), avoiding reintubation (8.905), and passing a spontaneous breathing trial (8.903). Passing a spontaneous breathing trial assumed greater importance after an initial failed attempt. "Time to event" outcomes were less important to visitors. We did not identify a preferred spontaneous breathing trial technique. Although ICU survival was the most important outcome at ICU admission and during the ICU stay, visitors rated quality of life higher than hospital survival at ICU discharge.
CONCLUSIONS: Visitors to critically ill patients prioritized two general outcomes (ICU and hospital survival) and three ventilation-related outcomes (being ventilator free, avoiding reintubation, passing a spontaneous breathing trial), and valued avoiding complications, maintaining quality of life, comfort, and returning to previous living arrangements. The outcomes preferences of the survey respondents evolved temporally during the ICU stay.

Entities:  

Keywords:  clinical outcomes; research methods; stakeholder engagement; trial design; weaning

Mesh:

Year:  2016        PMID: 27598009     DOI: 10.1513/AnnalsATS.201606-445OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  7 in total

1.  Applying participatory design to a pharmacy system intervention.

Authors:  Apoorva Reddy; Corey A Lester; Jamie A Stone; Richard J Holden; Cynthia H Phelan; Michelle A Chui
Journal:  Res Social Adm Pharm       Date:  2018-11-27

Review 2.  Trials directly comparing alternative spontaneous breathing trial techniques: a systematic review and meta-analysis.

Authors:  Karen E A Burns; Ibrahim Soliman; Neill K J Adhikari; Amer Zwein; Jessica T Y Wong; Carolina Gomez-Builes; Jose Augusto Pellegrini; Lu Chen; Nuttapol Rittayamai; Michael Sklar; Laurent J Brochard; Jan O Friedrich
Journal:  Crit Care       Date:  2017-06-01       Impact factor: 9.097

3.  Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia.

Authors:  Paul S Myles; Mark A Shulman; Stephane Heritier; Sophie Wallace; David R McIlroy; Stuart McCluskey; Isabella Sillar; Andrew Forbes
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

4.  Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT).

Authors:  Edward Litton; Matthew Anstey; David Broadhurst; Andy R Chapman; Andrew Currie; Janet Ferrier; Joel Gummer; Alisa Higgins; Jolene Lim; Laurens Manning; Erina Myers; Katrina Orr; Anne-Marie Palermo; Andrew Paparini; Susan Pellicano; Edward Raby; Anu Rammohan; Adrian Regli; Bernhard Richter; Sam Salman; Tobias Strunk; Sharon Waterson; Brad Wibrow; Fiona M Wood
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

5.  Frequency of Screening and SBT Technique Trial - North American Weaning Collaboration (FAST-NAWC): a protocol for a multicenter, factorial randomized trial.

Authors:  K E A Burns; Leena Rizvi; Deborah J Cook; Andrew J E Seely; Bram Rochwerg; Francois Lamontagne; John W Devlin; Peter Dodek; Michael Mayette; Maged Tanios; Audrey Gouskos; Phyllis Kay; Susan Mitchell; Kenneth C Kiedrowski; Nicholas S Hill
Journal:  Trials       Date:  2019-10-11       Impact factor: 2.279

6.  Days at Home after Surgery: An Integrated and Efficient Outcome Measure for Clinical Trials and Quality Assurance.

Authors:  Max Bell; Lars I Eriksson; Tobias Svensson; Linn Hallqvist; Fredrik Granath; Jennifer Reilly; Paul S Myles
Journal:  EClinicalMedicine       Date:  2019-04-27

7.  Patients as Researchers in Adult Critical Care Medicine. Fantasy or Reality?

Authors:  Kirsten M Fiest; Bonnie G Sept; Henry T Stelfox
Journal:  Ann Am Thorac Soc       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.